Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "sales"
Home
Why Rokit Healthcare’s Stock Soared Despite Geopolitical Volatility
Rokit Healthcare is capturing significant market attention for its robust momentum. Its stock price has surged 50% over eight trading sessions, even...
03/14/2026, 04:18 ET
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite hormone and chemotherapy.
03/12/2026, 03:27 ET
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
03/05/2026, 18:47 ET
Why Your Laundry Smells Even After Washing: Is Your Detergent to Blame?
If your clothes emerge from the wash with a persistent musty odor, it is natural to blame a lack of ventilation or a...
02/15/2026, 01:12 ET
Valentine’s Day Warning: Is Your "Healthy" Dark Chocolate Hiding Heavy Metals?
As Valentine’s Day approaches, chocolate sales are skyrocketing. Recently, health-conscious consumers have been...
02/13/2026, 02:11 ET
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January
Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...
02/13/2026, 02:03 ET
Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?
The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.
02/09/2026, 04:32 ET
LigaChemBio Receives Milestone from Czech Sotio Biotech
LigaChem Biosciences announced on the 9th that it will receive milestone payments based on successful product...
02/09/2026, 04:32 ET
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
02/05/2026, 04:06 ET
Celltrion "Asthma Drug 'Omrilclo' Captures 60% Market Share in Spain"
Celltrion announced on the 4th that its chronic spontaneous urticaria and allergic asthma treatment, 'Omrilclo ', is...
02/05/2026, 04:06 ET
Previous
5
6
7
8
Next